A growing number of genes have been identified in individuals with cerebral palsy (CP); however, many of these studies have poor compliance with the cerebral palsy clinical description. This systematic review aimed to assess the quality of the cerebral palsy clinical description/phenotype in cerebral palsy genetic studies published between 2010 and 2024 and report clinically relevant genes based on the quality of the cerebral palsy phenotype. An expert panel developed 6 criteria to review the reported cerebral palsy phenotype/description for each included study. Clinically relevant genes were extracted from each study and stratified into 2 tiers based on the quality. Eighteen studies were included. There was high confidence in the reported cerebral palsy description/phenotype from 8 studies. Of the initial 373 clinically relevant genes, 85 were tier II genes. Individual cerebral palsy motor disorder and phenotype data were absent for 349 of these individuals, limiting further analysis. The tier I gene list was composed of 6 genes: ATL1, COL4A1, GNAO1, KIF1A, SPAST, and TUBA1A. Bilateral spasticity was the most common motor disorder reported in individuals with variants in all 6 genes, and most individuals had accompanying conditions. Prioritizing the accurate reporting of motor and nonmotor phenotypes is crucial for future cerebral palsy genetic studies to further understand the underlying neurobiology.
RosenbaumPPanethNLevitonA, et al.A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8-14. Erratum in: Dev Med Child Neurol. 2007 Jun;49(6):480.
2.
DarHStewartKMcIntyreSPagetS. Multiple motor disorders in cerebral palsy. Dev Med Child Neurol. 2024;66(3):317-325. doi: https://doi.org/10.1111/dmcn.15730. Epub 2023 Aug 14.
3.
KorzeniewskiSJSlaughterJLenskiMHaakPPanethN. The complex aetiology of cerebral palsy. Nat Rev Neurol. 2018;14(9):528-543. doi: https://doi.org/10.1038/s41582-018-0043-6
van EykCLFaheyMCGeczJ. Redefining cerebral palsies as a diverse group of neurodevelopmental disorders with genetic aetiology. Nat Rev Neurol. 2023;19(9):542-555. doi: https://doi.org/10.1038/s41582-023-00847-6
6.
SrivastavaSLewisSACohenJS, et al.Molecular diagnostic yield of exome sequencing and chromosomal microarray in cerebral palsy: a systematic review and meta-analysis. JAMA Neurol. 2022;79(12):1287-1295. doi: https://doi.org/10.1001/jamaneurol.2022.3549
7.
Gonzalez-MantillaPJHuYMyersSM, et al.Diagnostic yield of exome sequencing in cerebral palsy and implications for genetic testing guidelines: a systematic review and meta-analysis. JAMA Pediatr. 2023;177(5):472-478. doi:https://doi.org/10.1001/jamapediatrics.2023.0008
8.
LiNZhouPTangH, et al.In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy. Brain. 2022;145(1):119-141. doi: https://doi.org/10.1093/brain/awab209
9.
FriedmanJMvan EssenPvan KarnebeekCDM. Cerebral palsy and related neuromotor disorders: overview of genetic and genomic studies. Mol Genet Metab. 2022;137(4):399-419. doi: https://doi.org/10.1016/j.ymgme.2021.11.001
10.
Invitae Cerebral Palsy Spectrum Disorders Panel: Test catalog. Invitae. Accessed September 9, 2023. https://www.invitae.com/en/providers/test-catalog/test-55004
11.
StarkZFoulgerREWilliamsE, et al.Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am J Hum Genet. 2021;108(9):1551-1557. doi: https://doi.org/10.1016/j.ajhg.2021.06.020
12.
PhamRMolBWGeczJ, et al.Definition and diagnosis of cerebral palsy in genetic studies: a systematic review. Dev Med Child Neurol. 2020;62(9):1024-1030. doi: https://doi.org/10.1111/dmcn.14585
13.
TakezawaYKikuchiAHaginoyaK, et al.Genomic analysis identifies masqueraders of full-term cerebral palsy. Ann Clin Transl Neurol. 2018;5(5):538-551. doi: https://doi.org/10.1002/acn3.551
14.
ZouvelouVYuberoDApostolakopoulouL, et al.The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center. Eur J Paediatr Neurol. 2019;23(3):427-437. doi: https://doi.org/10.1016/j.ejpn.2019.02.001
SchaafCPBetancurCYuenRKC, et al.A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat Rev Genet. 2020;21(6):367-376. doi: https://doi.org/10.1038/s41576-020-0231-2
17.
Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of cerebral palsy in Europe (SCPE). Dev Med Child Neurol. 2000;42(12):816-824. doi: https://doi.org/10.1017/s0012162200001511
18.
Smithers-SheedyHBadawiNBlairE, et al.What constitutes cerebral palsy in the twenty-first century?Dev Med Child Neurol. 2014;56(4):323-328. doi: https://doi.org/10.1111/dmcn.12262
19.
te VeldeAMorganCNovakITantsisEBadawiN. Early diagnosis and classification of cerebral palsy: an historical perspective and barriers to an early diagnosis. J Clin Med.2019;8(10):1599. doi: https://doi.org/10.3390/jcm8101599
20.
RichardsSAzizNBaleS, et al.ACMG Laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med.2015;17(5):405-424. doi: https://doi.org/10.1038/gim.2015.30
21.
PalisanoRRosenbaumPWalterSRussellDWoodEGaluppiB. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223. doi: https://doi.org/10.1111/j.1469-8749.1997.tb07414.x
22.
Online Mendelian Inheritance in Man (OMIM). Baltimore: eMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. Accessed 9 October, 2023. http://omim.org/.
23.
McMichaelGBainbridgeMNHaanE, et al.Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry. 2015;20(2):176-182. doi: https://doi.org/10.1038/mp.2014.189
24.
van EykCLCorbettMAFrankMSB, et al.Targeted resequencing identifies genes with recurrent variation in cerebral palsy. NPJ Genom Med. 2019;4:27. doi: https://doi.org/10.1038/s41525-019-0101-z
25.
RoselloMCaro-LlopisAOrellanaC, et al.Hidden etiology of cerebral palsy: genetic and clinical heterogeneity and efficient diagnosis by next-generation sequencing. Pediatr Res. 2021;90(2):284-288. doi: https://doi.org/10.1038/s41390-020-01250-3
26.
van EykCLWebberDLMinocheAE, et al.Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing. NPJ Genom Med. 2021;6(1):74. doi: https://doi.org/10.1038/s41525-021-00238-0
27.
YechieliMGulsunerSBen-PaziH, et al.Diagnostic yield of chromosomal microarray and trio whole exome sequencing in cryptogenic cerebral palsy. J Med Genet. 2022;59(8):759-767. doi: https://doi.org/10.1136/jmedgenet-2021-107884
28.
ChopraMGableDLLove-NicholsJ, et al.Mendelian etiologies identified with whole exome sequencing in cerebral palsy. Ann Clin Transl Neurol. 2022;9(2):193-205. doi: https://doi.org/10.1002/acn3.51506
29.
FehlingsDLZarreiMEngchuanW, et al.Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy. Nat Genet.2024;56(4):585-594. https://doi.org/10.1038/s41588-024-01686-x
30.
MayHJFasheunJABainJM, et al.Genetic testing in individuals with cerebral palsy. Dev Med Child Neurol. 2021;63(12):1448-1455. doi: https://doi.org/10.1111/dmcn.14948
31.
MeiHYangLXiaoT, et al.Genetic spectrum identified by exome sequencing in a Chinese pediatric cerebral palsy cohort. J Pediatr. 2022;242:206-212.e6. doi: https://doi.org/10.1016/j.jpeds.2021.11.019
32.
PavelekovaPNecpalJJechR, et al.Predictors of whole exome sequencing in dystonic cerebral palsy and cerebral palsy-like disorders. Parkinsonism Relat Disord. 2023 Jun;111:105352. doi: https://doi.org/10.1016/j.parkreldis.2023.105352
33.
Al ZahraniHSiriwardenaKYoungDLehmanAHorvathGAGoezH. Genomics in cerebral palsy phenotype across the lifespan: comparison of diagnostic yield between children and adult population. Mol Genet Metab. 2022;137(4):420-427. doi: https://doi.org/10.1016/j.ymgme.2021.07.007
34.
NejabatMInalooSSheshdehAT, et al.Genetic testing in various neurodevelopmental disorders which manifest as cerebral palsy: a case study from Iran. Front Pediatr. 2021;9:734946. doi: https://doi.org/10.3389/fped.2021.734946
Moreno-De-LucaAMillanFPesacretaDR, et al.Molecular diagnostic yield of exome sequencing in patients with cerebral palsy. JAMA. 2021;325(5):467-475. doi: https://doi.org/10.1001/jama.2020.26148
37.
SchüleRWiethoffSMartusP, et al.Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79(4):646-658. doi: https://doi.org/10.1002/ana.24611
38.
NicitaFGinevrinoMTravagliniL, et al.Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet. 2021;58(7):475-483. doi: https://doi.org/10.1136/jmedgenet-2020-107007
39.
WynnDPPulstSM. A novel WDR45 mutation in a patient with β-propeller protein-associated neurodegeneration. Neurol Genet. 2016;3(1):e124. doi: https://doi.org/10.1212/NXG.0000000000000124
40.
AlecuJESaffariAJordanCSrivastavaSBlackstoneCEbrahimi-FakhariD. De novo variants cause complex symptoms in HSP-ATL1 (SPG3A) and uncover genotype-phenotype correlations. Hum Mol Genet.2023;32(1):93-103. doi: https://doi.org/10.1093/hmg/ddac182. Erratum in: Hum Mol Genet. 2023 Sep 5;32(18):2856.
41.
ParodiLFenuSBarbierM, et al.Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. Brain.2018;141(12):3331-3342. doi: https://doi.org/10.1093/brain/awy285
42.
SchievingJHde BotSTvan de PolLA, et al.De novo SPAST mutations may cause a complex SPG4 phenotype. Brain.2019;142(7):e31. doi: https://doi.org/10.1093/brain/awz140
43.
CrawfordKXianJHelbigKL, et al.Computational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders. Genet Med.2021;23(7):1263-1272. doi: https://doi.org/10.1038/s41436-021-01120-1
44.
MorsyHBenkiraneMCaliE, et al.Expanding SPTAN1 monoallelic variant associated disorders: from epileptic encephalopathy to pure spastic paraplegia and ataxia. Genet Med.2023;25(1):76-89. doi:https://doi.org/10.1016/j.gim.2022.09.013
45.
ParentiIRabanedaLGSchoenHNovarinoG. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 2020;43(8):608-621. doi: https://doi.org/10.1016/j.tins.2020.05.004
46.
MagrinelliFBalintBBhatiaKP. Challenges in clinicogenetic correlations: one gene - many phenotypes. Mov Disord Clin Pract. 2021;8(3):299-310. doi: https://doi.org/10.1002/mdc3.13165
47.
WrightCFWestBTukeM, et al.Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting. Am J Hum Genet. 2019;104(2):275-286. doi: https://doi.org/10.1016/j.ajhg.2018.12.015
48.
PoseyJEHarelTLiuP, et al.Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376(1):21-31. doi: https://doi.org/10.1056/NEJMoa1516767
49.
RosinaEPezzaniLPezzoliL, et al.Atypical, composite, or blended phenotypes: how different molecular mechanisms could associate in double-diagnosed patients. Genes (Basel). 2022;13(7):1275. doi: https://doi.org/10.3390/genes13071275
50.
WilsonYASmithers-SheedyHOstojicK, et al.Common data elements to standardize genomics studies in cerebral palsy. Dev Med Child Neurol. 2022;64(12):1470-1476. doi: https://doi.org/10.1111/dmcn.15245
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
